期刊文献+

甲状腺功能亢进症与凝血功能 被引量:4

Hyperthyroidism and Coagulation
下载PDF
导出
摘要 甲状腺疾病患者可发生凝血参数异常和临床凝血功能紊乱,甚至出现血栓或出血。与甲状腺功能亢进症(甲亢)有关的大多数凝血异常是甲状腺激素对各种凝血参数直接作用的结果,自身免疫因素也影响甲亢凝血过程。甲亢患者升高的甲状腺激素水平可影响凝血因子合成和作用、血管内皮细胞分泌、血小板成熟和功能等,从而导致凝血状态改变并有发生血栓形成的倾向。因此,应评估甲亢患者的凝血状态。 Thyroid disorders may cause abnormal coagulation parameters and clinical coagulation disorders,even thrombsis or bleeding.Most of the hemostatic abnormalities associated with hyperthyroidism are the consequences of direct effects of thyroid hormones on various hemostatic parameters.Thyroid autoimmunity also affects the procession of coagulation.Excess of thyroid hormone can affect the synthesis and function of coagulation factors,vascular endothelial cells secretion,maturation and the function of platelets,which result in changes of coagulation status in patients with hyperthyroidism and may result in thrombsis.Therefore,coagulation status of patients with hyperthyroidism should be assessed.
出处 《医学综述》 2012年第12期1833-1835,共3页 Medical Recapitulate
关键词 甲状腺功能亢进症 凝血 甲状腺激素 Hyperthyroidism Coagulation Thyroid hormones
  • 相关文献

参考文献28

  • 1Erem C, Ersoz I-IO, Karti SS ,et al. Blood coagulation and fibrinoly- sis in patients with hyperthyroidism[ J]. J Endocrinol Invest,2002, 25(4) :345-350.
  • 2Parker LJ, Lawson DH. Death from thyrotoxicosis [ J ]. Lancet, 1973,2 (7834) :894-895.
  • 3Loeliger EA,van der Esch B ,Mattem MJ ,et al. The biological dis- appearance rate of prothrombin, factor V~, IX and X from plasma in hypothyroidism, hyperthyroidism, and during fever [ J ]. Thromb Diath Haemorrh, 1964,10:267-277.
  • 4Kellet HA, Sawers JA, Boulton FE, et al. Problems of anticoagula- tion with warfarin in hyperthyroidism [ J ]. Q j Med, 1986, 58 (225) :43-51.
  • 5史海庆,郝明巨,凌欣,李蓉.甲亢患者血浆Fib、APTT和D-D水平检测及意义[J].江苏医药,2010,36(11):1264-1265. 被引量:6
  • 6Marongiu F ,Conti M, Mameli G, et al. Fibrinogen and fibrlnolytic activity in hyperthyroidism before and after antithyroid treatment [ J ]. J Endocrinol Invest, 1988,11 ( 10 ) :723-725.
  • 7Marongiu F, Conti M, Murtas ML, et al. Activation of blood coagu- lation and fibrinolysis in Graves' disease [ J ]. Horm Metab Res, 1991,23(12) :609-611.
  • 8Burggraaf J, Lalezari S, Emeis JJ, et al. Endothelial function in pa- tients with hyperthyroidism before and aftert reatment wit proprano- lol and thiamazol[ J]. Thyreid,2001,11 (2) :153-160.
  • 9门剑龙,高硕.甲状腺功能紊乱患者止凝血功能异常的研究[J].中华检验医学杂志,2010,33(4):309-314. 被引量:15
  • 10Adam 55, Key NS, Greenberg GS. D-dimer antigen:current concepts and fut~e prospects [ J ]. Blood,2009,113 ( 13 ) :2878 -2887.

二级参考文献23

  • 1魏玉香,殷宗健,丛玉隆,张立文.肝硬化患者纤溶活性变化与t-PA、PAⅠ的关系[J].山东医药,2004,44(31):12-13. 被引量:1
  • 2Squizzato A,Bomualdi E,Buller HR,et al.Clinical review:Thyroid dysfunction and effects on coagulation and fibrinolysis:a systematic review.J Clin Endocrinol Metab,2007,92:2415-2420.
  • 3Manfredi E,van Zaane B,Gerdes VE,et al.Hypothymidsm and acquired von Willebrand's syndrome:a systematic review.Haemophilia,2008,14:423-433.
  • 4Kurnik D,Loebstein R,Farfel z,et al.Complex drug-drug-disease interactions between amiodalone,warfarin,and the thyroid gland.Medicine(Baltimore),2004,83:107-113.
  • 5Duntas LH,Wartofshy L.Cardiovascular risk and subclinical hypothyroidism:focus on lipids and new emerging risk factors.What is the evidence?Thyroid,2007,17:1075-1084.
  • 6Neves c,Alves M,Medina JL,et al.Thyroid diseases,dyslipidemia and cardiovascular pathology.Rey Port Cardiol,2008,27:1211-1136.
  • 7squizzato A,Gerdes VE.Thyroid disease and haemostasis-a relationship with clinical implications?Thromb Haemost,2008,100:727-728.
  • 8Manfredi E,van Zaane B,Gerdes VEA,et al.Hypothyroidism and acquired von Willebrand's syndrome:a systematic review.Haemophilia,2008,14:423-433.
  • 9Yavuz DG,Yazici D,Toprak A,et al.Exogenous subclinical hyperthyroidism impairs endothelial function in nodular goiter patients.Thyroid,2008,18:395-400.
  • 10Modzelewska A,Szelachowska M,Zonenberg A.et al.Selected markers of endothelial dysfunction in patients with subclinical and overt hyperthyroidism.Endokrynol Pol,2006,57:202-210.

共引文献18

同被引文献32

  • 1郭雅卿,崔建双,华文芳.甲状腺功能异常与大血管病变的研究[J].中外健康文摘,2012,9(12):451-452.
  • 2国杨,徐予,唐熠达,等.冠心病合并房颤患者的甲状腺激素水平变化及临床意义[J].中国循环杂志,2013,5(1):133-134.
  • 3Mozaffarian D, Benjamin [J, Go AS, et al. Heart disease and stroke statistics- 2015 update: a report from the American Heart Association I-J]. Circulation, 2015,131(4) :329-322.
  • 4Mancini A, Raimondo S, Di Segni C, et al. Thyroid hormones and antioxidant systems., focus on oxidative stress in cardiovas- cular and pulmonary diseases[J]. Int J Mol Sci, 2013, 14(12) : 23893-909.
  • 5Collet TH, Bauer DC, Cappola AR, et al. Thyroid antibodystatus, subclinical hypothyroidism, and the risk of coronary heart disease:an individual participant data analysis [J]. J Clin Endocrinol Metab, 2014, 99(9):3353-62.
  • 6Chen WJ, Yeh YH, Lin KH,et al. Molecular characterization of thyroid hormone-inhibited atrial L-type calcium channel ex- pression: implication for atrial fibrillation in hyperthyroidism [J]. Basic Res Cardiol, 2011,106(2): 163-74.
  • 7朱长举,李福琴,王万鹏,刘海燕,朱志强,刘保池,张宏涛.肠坏死临床分析[J].医药论坛杂志,2008,29(15):17-18. 被引量:2
  • 8史海庆,郝明巨,凌欣,李蓉.甲亢患者血浆Fib、APTT和D-D水平检测及意义[J].江苏医药,2010,36(11):1264-1265. 被引量:6
  • 9谢于,孙强,卞策,刘翔,阎涛.肠系膜静脉血栓并肠坏死的诊治[J].医学理论与实践,2011,24(8):873-874. 被引量:1
  • 10谢晓民,陈晶.血小板活化与相关疾病的研究进展[J].河北医药,2012,34(3):437-439. 被引量:17

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部